AKT1 and hepatocellular carcinoma: Furthermore, heightened expression of TPX2 in HCC promotes cell proliferation and invasion through AKT signaling activation and upregulation of MMP2/9, underscoring its potential as a therapeutic target for hepatocellular carcinoma (Liu et al., 2014).